Rating History for Acceleron Pharma (XLRN) by Raymond James

More Stocks Rated by Raymond James | Latest Ratings for XLRN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/4/2021 Danielle Brill Downgrade Market Perform
(Strong Buy)		 N/A
(N/A)		 174.35
(178.75)		 2.52% Details